Current Assets
Inventories
Pfizer Inventories increased by 3.9% to $2.46B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.9%, from $2.79B to $2.46B. Over 5 years (FY 2020 to FY 2025), Inventories shows an upward trend with a 21.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
Rising inventory levels can signal anticipated demand growth or potential overproduction and obsolescence risks.
Detailed definition
This includes the value of raw materials, work-in-progress, and finished pharmaceutical products held for sale. It is a...
Peer comparison
High inventory levels are typical in pharma due to long manufacturing lead times and regulatory compliance requirements.
Metric ID:
inventoriesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $981M | $935M | $939M | $894M | $943M | $3.33B | $5.83B | $5.62B | $5.87B | $1.42B | $4.57B | $3.36B | $2.92B | $2.77B | $2.66B | $2.79B | $2.36B | $2.14B | $2.37B | $2.46B |
| QoQ Change | — | -4.7% | +0.4% | -4.8% | +5.5% | +252.8% | +75.1% | -3.6% | +4.5% | -75.9% | +222.6% | -26.4% | -13.2% | -5.2% | -3.7% | +4.9% | -15.5% | -9.2% | +10.6% | +3.9% |
| YoY Change | — | — | — | — | -3.9% | +255.8% | +520.6% | +528.2% | +522.3% | -57.4% | -21.6% | -40.2% | -50.3% | +95.3% | -41.7% | -16.9% | -19.1% | -22.5% | -11.0% | -11.9% |
Range$894M – $5.87B
CAGR+21.4%
Avg YoY Growth+101.6%
Median YoY Growth-14.4%
Current Streak2 quarters growth
Inventories at Other Companies
Frequently Asked Questions
- What is Pfizer's inventories?
- Pfizer (PFE) reported inventories of $2.46B in Q1 2026.
- How has Pfizer's inventories changed year-over-year?
- Pfizer's inventories decreased by 11.9% year-over-year, from $2.79B to $2.46B.
- What is the long-term trend for Pfizer's inventories?
- Over 5 years (2020 to 2025), Pfizer's inventories has grown at a 21.6% compound annual growth rate (CAGR), from $890M to $2.37B.
- What does inventories mean?
- The total value of all goods and materials the company currently has in stock.